Literature DB >> 32653319

The urge to implement and expand telepsychiatry during the COVID-19 crisis: Early career psychiatrists' perspective.

Andre Luiz Schuh Teixeira1, Alex Vicente Spadini2, Victor Pereira-Sanchez3, Margaret Isioma Ojeahere4, Kana Morimoto5, Alice Chang6, Renato de Filippis7, Joan Soler-Vidal8.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32653319      PMCID: PMC7290184          DOI: 10.1016/j.rpsm.2020.06.001

Source DB:  PubMed          Journal:  Rev Psiquiatr Salud Ment (Engl Ed)        ISSN: 2173-5050


× No keyword cloud information.
Dear Editor, If few months ago, psychiatrists were told that their practice would be transformed and mental health care would be compelled to reinvent due to a respiratory syndrome, few would have believed it. However, an unforeseen severe global health crisis is leading to significant changes in the field of psychiatry. Currently, there are millions of cases and hundreds of thousands of deaths confirmed worldwide with coronavirus disease 2019 (COVID-19), an illness classified by the World Health Organization as a global pandemic. Because effective treatments or vaccines for the SARS-CoV-2 are still nonexistent, social distancing and isolation remain the most successful strategies to prevent countries from humanitarian disasters and collapse of their national health systems. However, diseases other than COVID-19 still exist, and their burden may be worsened by the emergency situation and the effects of quarantine. Despite the disruptions in the normal functioning of psychiatric services, which have limited the ability to provide regular care, especially in outpatient settings, patients with new and existing mental health conditions should be followed up remotely. This is more compelling for patients with previous severe mental disorders or new-onset severe emotional distress, in which the consequences of destabilization or suicidality could be fatal. In these cases, telepsychiatry is called to be a game changer. Telemedicine is defined by the American Psychiatric Association as “the process of providing health care from a distance through technology, often using videoconferencing”. Telepsychiatry, a subgroup of telemedicine, involves providing psychiatric care through a range of services including psychiatric evaluations, therapy, patient education and medication management. Early Career Psychiatrists (ECPs) from several regions of the world are optimistic that this pandemic will provide the opportunity to implement and expand telepsychiatry to urgently address the current mental health care needs of the population in times of physical distancing.4, 5 Indeed, telepsychiatry has already become a powerful tool in the mental health with demonstrated effectiveness in US and Australia for disorders like depression, anxiety, psychosis and PTSD. Therefore, it may be used even for patients suffering from COVID-19, people impacted by confinement, and frontline health workers. Historically, times of crisis have provided opportunities for major developments and breakthroughs. The current one has the potential to show that technology can facilitate access to mental health care. Telemedicine has been demonstrated to have good acceptability among patients and clinicians, as well as an effectiveness comparable to face-to-face interventions. Nevertheless, traditional psychiatric services have been slow to take up digital forms of care delivery. Many barriers have to be considered, from affordability to ethical concerns such as confidentiality and safety. From the service users side, even the senior citizens technological gap could be a limitation to telepsychiatry spread, especially concerning configuration and usability of digital devices. Moreover, in order to implement telepsychiatry, it is necessary to provide training and protocols. Nevertheless, the present circumstances show the necessity to tackle them, for example with secure channels, electronic prescription systems to avoid patients to go to the clinic to have their prescription updated, and developing guidelines adapted from those countries which have been using telemedicine for years and modifying them to different cultural, technical, legal and practice contexts for clinical best practice. Availability of telepsychiatry may vary from place to place. In countries where it is well established and online platforms exist, a patient can schedule a video conferencing with their provider. In low- and middle-income countries telepsychiatry is still incipient despite its demonstrated cost-effectiveness. It is also necessary to institute new legal regulations to encourage the use of technology while ensuring best practices. Our patients can no longer wait. In these difficult times, we cannot stop providing psychiatric care, and telepsychiatry is the tool that psychiatrists should adopt to overcome the obstacles that the coronavirus outbreak has imposed and to help patients in isolation. We can provide hybrid forms of care, while recognizing the importance of traditional face-to-face care. Right now, we have the necessary technology to improve access to healthcare with low cost and high efficiency. Our adoption of telepsychiatry now will be the basis of future developments after the pandemic. Furthermore, technology might even improve doctor–patient relationships by enhancing more communication opportunities. ECPs must lead the change to increase the use of telemedicine in psychiatry. Our mission to alleviate mental suffering should not be overshadowed by personal hesitation or resistance to the new. We invite ECPs from all over the world to participate in what can be a mental health revolution for the benefit of patients. We need telepsychiatry, and we need it now.

Authors’ contributions

AST, AS, RdF and JSV led the group discussion and manuscript drafting. VPS, MO, KM and AC reviewed the manuscript. All the authors agreed on the final draft before submission.
  9 in total

1.  Acceptability, Usability, and Effectiveness: A Qualitative Study Evaluating a Pediatric Telemedicine Program.

Authors:  Hadley S Sauers-Ford; Michelle Y Hamline; Melissa M Gosdin; Laura R Kair; Gary M Weinberg; James P Marcin; Jennifer L Rosenthal
Journal:  Acad Emerg Med       Date:  2019-05-02       Impact factor: 3.451

2.  Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial.

Authors:  John C Fortney; Jeffrey M Pyne; Timothy A Kimbrell; Teresa J Hudson; Dean E Robinson; Ronald Schneider; William M Moore; Paul J Custer; Kathleen M Grubbs; Paula P Schnurr
Journal:  JAMA Psychiatry       Date:  2015-01       Impact factor: 21.596

Review 3.  E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions.

Authors:  Hiran Thabrew; Karolina Stasiak; Sarah E Hetrick; Stephen Wong; Jessica H Huss; Sally N Merry
Journal:  Cochrane Database Syst Rev       Date:  2018-08-15

Review 4.  Use of mobile technologies in patients with psychosis: A systematic review.

Authors:  Lucia Bonet; Clara Izquierdo; Maria Jose Escartí; José Vicente Sancho; David Arce; Ignacio Blanquer; Julio Sanjuan
Journal:  Rev Psiquiatr Salud Ment       Date:  2017-03-01       Impact factor: 3.318

5.  Psychotherapy for depression in older veterans via telemedicine: a randomised, open-label, non-inferiority trial.

Authors:  Leonard E Egede; Ron Acierno; Rebecca G Knapp; Carl Lejuez; Melba Hernandez-Tejada; Elizabeth H Payne; B Christopher Frueh
Journal:  Lancet Psychiatry       Date:  2015-07-16       Impact factor: 27.083

6.  Effectiveness of a Multimodal Digital Psychotherapy Platform for Adult Depression: A Naturalistic Feasibility Study.

Authors:  Enitan T Marcelle; Laura Nolting; Stephen P Hinshaw; Adrian Aguilera
Journal:  JMIR Mhealth Uhealth       Date:  2019-01-23       Impact factor: 4.773

7.  COVID-19 effect on mental health: patients and workforce.

Authors:  Victor Pereira-Sanchez; Frances Adiukwu; Samer El Hayek; Drita Gashi Bytyçi; Jairo M Gonzalez-Diaz; Ganesh Kudva Kundadak; Amine Larnaout; Marwa Nofal; Laura Orsolini; Rodrigo Ramalho; Ramdas Ransing; Mohammadreza Shalbafan; Joan Soler-Vidal; Zulvia Syarif; Andre Luiz Schuh Teixeira; Mariana Pinto da Costa
Journal:  Lancet Psychiatry       Date:  2020-05-20       Impact factor: 27.083

8.  Patients with mental health disorders in the COVID-19 epidemic.

Authors:  Hao Yao; Jian-Hua Chen; Yi-Feng Xu
Journal:  Lancet Psychiatry       Date:  2020-04       Impact factor: 27.083

9.  COVID-19 and rationally layered social distancing.

Authors:  Richard A Stein
Journal:  Int J Clin Pract       Date:  2020-04-06       Impact factor: 3.149

  9 in total
  9 in total

1. 

Authors:  Ilaria Riboldi; Daniele Cavaleri; Angela Calabrese; Chiara Alessandra Capogrosso; Susanna Piacenti; Francesco Bartoli; Cristina Crocamo; Giuseppe Carrà
Journal:  Rev Psiquiatr Salud Ment       Date:  2022-06-20       Impact factor: 6.795

2.  Effects of Covid-19 confinement on the mental health of children and adolescents in Spain.

Authors:  Juan Pablo Pizarro-Ruiz; Nuria Ordóñez-Camblor
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

3.  COVID-19 & psychiatric care: Need of a plan to prevent follow-up discontinuation.

Authors:  I Ullah; D Shabbir; R Ramalho; M Irfan; R de Filippis
Journal:  Encephale       Date:  2021-03-11       Impact factor: 1.291

4.  Training Initiative for Psychiatry Post-graduate students (TIPPS)-a Unique Early Career Psychiatry Training Initiative in India and Its Response to the COVID-19 Pandemic.

Authors:  Satish Suhas; Amitkumar Chougule; Raviteja Innamuri; Swarna Buddha Nayok; Sweta Sheth; Sachin Nagendrappa; Krishna G Patel; Sharanya B Shetty; Bhargavi Nagendra; Udayan Bhaumik; Sharnita Pugalenthi; Gaurav Uppal; Girish N Babu; Naren P Rao; Rishikesh V Behere
Journal:  Acad Psychiatry       Date:  2022-01-14

Review 5.  Suicidal behavior sociocultural factors in developing countries during COVID-19.

Authors:  S Shoib; J E T Gaitán Buitrago; K H Shuja; M Aqeel; R de Filippis; J Abbas; I Ullah; S M Y Arafat
Journal:  Encephale       Date:  2021-09-23       Impact factor: 1.291

6.  Grief experience among ICU staff with loss of family members during COVID-19 outbreak in IRAN: A qualitative study.

Authors:  Shabnam Nohesara; Mahdieh Saeidi; Hesam Mosavari; Leila Ghalichi; Mahmoud Reza Alebouyeh
Journal:  Front Psychiatry       Date:  2022-07-18       Impact factor: 5.435

Review 7.  Coronavirus outbreak from early career psychiatrists' viewpoint: What we have learned so far.

Authors:  Renato de Filippis; Joan Soler-Vidal; Victor Pereira-Sanchez; Margaret Isioma Ojeahere; Kana Morimoto; Alice Chang; Andre Luiz Schuh Teixeira; Alex Vicente Spadini
Journal:  Perspect Psychiatr Care       Date:  2021-06-01       Impact factor: 2.223

8.  Management of psychiatric conditions and delirium during the COVID-19 pandemic across continents: lessons learned and recommendations.

Authors:  Margaret Isioma Ojeahere; Renato de Filippis; Ramdas Ransing; Ruta Karaliuniene; Irfan Ullah; Drita Gashi Bytyçi; Zargham Abbass; Ozge Kilic; Mahsa Nahidi; Nafisatu Hayatudeen; Sachin Nagendrappa; Sheikh Shoib; Chonnakarn Jatchavala; Amine Larnaout; Tanay Maiti; Oluseun Peter Ogunnubi; Samer El Hayek; Maya Bizri; Andre Luiz Schuh Teixeira; Victor Pereira-Sanchez; Mariana Pinto da Costa
Journal:  Brain Behav Immun Health       Date:  2020-09-19

9.  Adapting an Outpatient Psychiatric Clinic to Telehealth During the COVID-19 Pandemic: A Practice Perspective.

Authors:  Farzan Sasangohar; Major R Bradshaw; Marianne Millen Carlson; James N Flack; James C Fowler; Diana Freeland; John Head; Kate Marder; William Orme; Benjamin Weinstein; Jacob M Kolman; Bita Kash; Alok Madan
Journal:  J Med Internet Res       Date:  2020-10-01       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.